Gevo officer proposes $154K sale of common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gevo, Inc. officer Ryan Christopher Michael reported a proposed sale of 87,700 common shares, with an aggregate market value of $154,334.46 and an approximate sale date of May 27, 2026. The shares were acquired from the issuer as restricted stock awards on May 22, 2024; the amount acquired is listed as 183,333 shares.
Separate prior-sale entries name Christopher Ryan: 100,000 common shares sold March 30, 2026, for gross proceeds of $275,740.00, and 29,797 shares sold March 31, 2026, for gross proceeds of $88,175.00. The reported plan adoption or giving-of-instruction date is November 19, 2025.
Key Figures
Key Terms
Restricted Stock Awards financial
Rule 10b5-1 regulatory
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior GEVO stock sales are listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.